CRISPR-Cas9 in Clinical Oncology
How gene-editing technologies are moving from laboratory breakthroughs to targeted cancer therapies and personalized treatment protocols.
🧬
EDITOR'S PICK
Comprehensive, expert-verified coverage of clinical practice, biomedical research, public health, and the evolving landscape of human healing.
How gene-editing technologies are moving from laboratory breakthroughs to targeted cancer therapies and personalized treatment protocols.
Recent advances in liquid biopsies and neuroimaging that enable earlier diagnosis of Alzheimer's, Parkinson's, and ALS.
Machine learning models are compressing decade-long pharmaceutical development cycles into years, targeting previously undruggable proteins.
Updated treatment protocols for carbapenem-resistant infections
Expanded coverage beyond SARS-CoV-2 to influenza & Zika
Under peer review by 3 board-certified specialists
With over 20 years in clinical immunology and vaccine development, Dr. Rostova oversees the accuracy and clinical relevance of all Aevum Medicine entries, ensuring alignment with current WHO and FDA guidelines.